Their data support a model whereby human transposons are normally silenced by TDP-43, but that such silencing is reversed in a subset of ALS patients, which may lead to cellular toxicity (Tam et al., 2019). This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.